Novel inhalable gene therapy trialed for people with cystic fibrosis
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...
technologynetworks20 小时
Inhalable Gene Therapy Trial Begins for Cystic Fibrosis Patients
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis is being tested in human ...
PharmiWeb10 小时
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled ...
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)[1] and OXB,[2] today announce the start of LENTICLAIRTM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
Armed robbery in Revesby1 天
Inhalable Gene Therapy Trialled for Cystic Fibrosis
Researchers at Imperial College London are leading human trials for the innovative treatmentAn inhalable medicine with the potential to improve lung ...
EurekAlert!1 天
Novel inhalable gene therapy trialled for people with cystic fibrosis
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.